Arrhythmias & electrophysiologyGuideline or statement
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
- Clinical performance and quality measures statement
Recommendations
As issued by the authors
Performance measures: patients with newly diagnosed atrial fibrillation (AF) receive a basic clinical evaluation, with emphasis on secondary prevention at all stages of AF, documenting stroke risk and, if indicated, providing appropriate anticoagulation
Quality measures: measuring and addressing health inequities, optimizing antiarrhythmic or anticoagulant treatment, shared decision-making for rate- vs rhythm-control strategies, and, in appropriate patients, offering catheter ablation for HFrEF
Original publication
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation. J Am Coll Cardiol. Published 17 August 2026. doi:10.1016/j.jacc.2026.05.032
Summarised from the published abstract; every number is checked against it